Sharp Brains: Brain Fitness and Cognitive Health News

Neuroplasticity, Brain Fitness and Cognitive Health News

Icon

Epigenetics research opens potential door to prevent neurodevelopmental disorders

Sai Ma, for­mer Vir­ginia Tech bio­med­ical engi­neer­ing Ph.D. stu­dent, and Chang Lu, the Fred W. Bull pro­fes­sor of Chem­i­cal Engi­neer­ing at Vir­ginia Tech. Cred­it: Vir­ginia Tech

___

Epi­ge­net­ic Changes Guide Devel­op­ment of Dif­fer­ent Brain Regions (Dana Foun­da­tion):

It’s one of the great­est stand­ing mys­ter­ies in neu­ro­science: Giv­en that each cell in the human body con­tains the same DNA, how, exact­ly, does the brain devel­op into dis­tinct func­tion­al regions, sup­port­ed by dif­fer­ent cell types? And how might that devel­op­men­tal pro­gram go awry, result­ing in neu­rode­vel­op­men­tal dis­or­ders like schiz­o­phre­nia or autism? The answers may be the epigenome Read the rest of this entry »

Study: Psychedelics can promote neural plasticity in the prefrontal cortex and expand pathways for mental health

– Cred­it: Cell Reports 2018 23, 3170–3182DOI: (10.1016/j.celrep.2018.05.022). Copy­right © 2018 The Authors

___

Psy­che­delics in Neu­rol­o­gy: Poten­tial for Improv­ing Neu­ro­plas­tic­i­ty (Neu­rol­o­gy­Times):

Back in the 1950s, research was prov­ing that psy­che­del­ic agents could be effec­tive in the treat­ment of var­i­ous neu­ropsy­chi­atric dis­or­ders. Unfor­tu­nate­ly, just as sci­ence was explor­ing their ben­e­fi­cial effects, the coun­ter­cul­ture was explor­ing and embrac­ing their effects. Slow­ly but sure­ly, psy­che­delics were asso­ci­at­ed with rebel­lious youth and the tumul­tuous anti-war move­ment. As a result, the gov­ern­ment shut down most of the research.

The 1990s saw renewed inter­est in psy­che­del­ic com­pounds as a means to address neu­ropsy­chi­atric dis­or­ders. Research explored the ben­e­fits of MDMA and ket­a­mine to treat mood dis­or­ders and post­trau­mat­ic stress dis­or­der. Now, a new study sheds even more light on the promise these agents might pro­vide. Read the rest of this entry »

The Luria Neuroscience Institute announces new webinar series on Executive Functions, Dementia, TBI, Creativity and more

Hap­py to share that the Luria Neu­ro­science Insti­tute, an esteemed Part­ner of the 2017 Sharp­Brains Vir­tu­al Sum­mit, is host­ing a new webi­nar series aimed at bet­ter equip­ping pro­fes­sion­als help­ing those with men­tal health and with brain and brain dis­or­ders.

Dates and top­ics: Read the rest of this entry »

Mental health meets the digital revolution: Mindstrong Health raises $14 million to modernize the diagnosis and treatment of neuropsychiatric disorders via artificial intelligence (AI) and smartphones

Mind­strong Health Rais­es $14 Mil­lion in Series-A Fund­ing (press release):

Mind­strong Health, a start­up trans­form­ing the diag­no­sis and treat­ment of neu­ropsy­chi­atric dis­or­ders through the pow­er of AI and ubiq­ui­tous mobile tech­nol­o­gy, today announced that it has secured a $14 mil­lion round of Series-A fund­ing. Led by Fore­site Cap­i­tal and ARCH Ven­ture Part­ners, the round includ­ed Read the rest of this entry »

Augmenting physiotherapy via neurofeedback and neurostimulation: Key neurotechnology patent #43

therapy control

– Illus­tra­tive image from U.S. Patent No. 8,121,694

Today we are shar­ing a fas­ci­nat­ing patent from Medtron­ic.  (As men­tioned, we are fea­tur­ing 50 foun­da­tion­al Per­va­sive Neu­rotech patents, from old­er to new­er by issue date)

U.S. Patent No. 8,121,694: Therapy control based on a patient movement state

  • Assignee(s): Medtron­ic, Inc.
  • Inventor(s): Gre­go­ry F. Mol­nar, Steven S. Gill, Kei­th A, Miesel, Mark S. Lent, Tim­o­thy J. Deni­son, Eric J. Panken, Carl D. Wahlstrand, Jonathan C. Werder
  • Tech­nol­o­gy Cat­e­go­ry: Neu­ro-mon­i­tor­ing
  • Issue Date: Feb­ru­ary 21, 2012

SharpBrains’ Take:

The ‘694 patent dis­clos­es meth­ods to treat patients afflict­ed with move­ment or oth­er neu­rode­gen­er­a­tive dis­or­ders through brain-sig­nal feed­back. Read the rest of this entry »

About SharpBrains

As seen in The New York Times, The Wall Street Journal, BBC News, CNN, Reuters and more, SharpBrains is an independent market research firm tracking health and performance applications of brain science.

Follow us and Engage via…

twitter_logo_header
RSS Feed

Search for anything brain-related in our article archives

Enter Your Email to receive Sharp­Brains free, monthly eNewslet­ter:

Join more than 50,000 Sub­scribers and stay informed and engaged.